Annual CFF
$168.44 M
-$624.83 M-78.77%
December 31, 2023
Summary
- As of February 12, 2025, INSM annual cash flow from financing activities is $168.44 million, with the most recent change of -$624.83 million (-78.77%) on December 31, 2023.
- During the last 3 years, INSM annual CFF has fallen by -$102.56 million (-37.85%).
- INSM annual CFF is now -78.77% below its all-time high of $793.27 million, reached on December 31, 2022.
Performance
INSM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$397.20 M
-$384.29 M-49.17%
September 30, 2024
Summary
- As of February 12, 2025, INSM quarterly cash flow from financing activities is $397.20 million, with the most recent change of -$384.29 million (-49.17%) on September 30, 2024.
- Over the past year, INSM quarterly CFF has increased by +$395.95 million (+31701.44%).
- INSM quarterly CFF is now -49.17% below its all-time high of $781.49 million, reached on June 30, 2024.
Performance
INSM Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$1.30 B
+$395.95 M+43.56%
September 30, 2024
Summary
- As of February 12, 2025, INSM TTM cash flow from financing activities is $1.30 billion, with the most recent change of +$395.95 million (+43.56%) on September 30, 2024.
- Over the past year, INSM TTM CFF has increased by +$516.41 million (+65.49%).
- INSM TTM CFF is now at all-time high.
Performance
INSM TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
INSM Cash From Financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -78.8% | +10000.0% | +65.5% |
3 y3 years | -37.9% | +10000.0% | +65.5% |
5 y5 years | -56.5% | +10000.0% | +65.5% |
INSM Cash From Financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -78.8% | at low | -49.2% | >+9999.0% | at high | +6109.4% |
5 y | 5-year | -78.8% | at low | -49.2% | >+9999.0% | at high | +6109.4% |
alltime | all time | -78.8% | +8159.3% | -49.2% | >+9999.0% | at high | >+9999.0% |
Insmed Incorporated Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $397.20 M(-49.2%) | $1.30 B(+43.6%) |
Jun 2024 | - | $781.49 M(>+9900.0%) | $909.03 M(+428.9%) |
Mar 2024 | - | $3.02 M(-97.5%) | $171.86 M(+2.0%) |
Dec 2023 | $168.44 M(-78.8%) | $123.26 M(+9768.9%) | $168.44 M(-78.6%) |
Sep 2023 | - | $1.25 M(-97.2%) | $788.56 M(-4.4%) |
Jun 2023 | - | $44.33 M(<-9900.0%) | $824.43 M(+4.8%) |
Mar 2023 | - | -$399.00 K(-100.1%) | $786.41 M(-0.9%) |
Dec 2022 | $793.27 M(+29.5%) | $743.39 M(+1902.9%) | $793.27 M(+1326.9%) |
Sep 2022 | - | $37.12 M(+488.1%) | $55.60 M(+164.5%) |
Jun 2022 | - | $6.31 M(-2.3%) | $21.02 M(-96.6%) |
Mar 2022 | - | $6.46 M(+13.1%) | $612.30 M(-0.0%) |
Dec 2021 | $612.55 M(+126.0%) | $5.71 M(+125.2%) | $612.55 M(-1.0%) |
Sep 2021 | - | $2.54 M(-99.6%) | $618.85 M(-0.6%) |
Jun 2021 | - | $597.60 M(+8815.4%) | $622.41 M(+125.9%) |
Mar 2021 | - | $6.70 M(-44.2%) | $275.57 M(+1.7%) |
Dec 2020 | $271.00 M(-5.0%) | $12.01 M(+96.8%) | $271.00 M(+1.0%) |
Sep 2020 | - | $6.10 M(-97.6%) | $268.23 M(+1.8%) |
Jun 2020 | - | $250.76 M(>+9900.0%) | $263.49 M(-7.3%) |
Mar 2020 | - | $2.13 M(-76.9%) | $284.36 M(-0.3%) |
Dec 2019 | $285.28 M(-26.2%) | $9.24 M(+580.3%) | $285.28 M(+2.4%) |
Sep 2019 | - | $1.36 M(-99.5%) | $278.46 M(+0.3%) |
Jun 2019 | - | $271.63 M(+8808.9%) | $277.71 M(+2288.7%) |
Mar 2019 | - | $3.05 M(+25.8%) | $11.63 M(-97.0%) |
Dec 2018 | $386.74 M(+1.5%) | $2.42 M(+300.5%) | $386.74 M(+0.5%) |
Sep 2018 | - | $605.00 K(-89.1%) | $384.75 M(-49.5%) |
Jun 2018 | - | $5.55 M(-98.5%) | $762.37 M(+0.5%) |
Mar 2018 | - | $378.17 M(>+9900.0%) | $758.69 M(+99.1%) |
Dec 2017 | $381.09 M(+1142.4%) | $433.00 K(-99.9%) | $381.09 M(-5.1%) |
Sep 2017 | - | $378.22 M(>+9900.0%) | $401.51 M(+1117.5%) |
Jun 2017 | - | $1.87 M(+230.8%) | $32.98 M(+5.8%) |
Mar 2017 | - | $565.00 K(-97.3%) | $31.16 M(+1.6%) |
Dec 2016 | $30.67 M(-86.5%) | $20.85 M(+115.2%) | $30.67 M(+216.8%) |
Sep 2016 | - | $9.69 M(>+9900.0%) | $9.68 M(+1089.3%) |
Jun 2016 | - | $47.00 K(-42.0%) | $814.00 K(-99.6%) |
Mar 2016 | - | $81.00 K(-158.3%) | $226.41 M(-0.6%) |
Dec 2015 | $227.80 M(+97.9%) | -$139.00 K(-116.8%) | $227.80 M(-2.8%) |
Sep 2015 | - | $825.00 K(-99.6%) | $234.32 M(-31.5%) |
Jun 2015 | - | $225.64 M(>+9900.0%) | $341.93 M(+194.2%) |
Mar 2015 | - | $1.48 M(-76.9%) | $116.23 M(+1.0%) |
Dec 2014 | $115.09 M(+68.1%) | $6.37 M(-94.1%) | $115.09 M(+5.8%) |
Sep 2014 | - | $108.44 M(<-9900.0%) | $108.75 M(+59.7%) |
Jun 2014 | - | -$60.00 K(-117.8%) | $68.11 M(-1.0%) |
Mar 2014 | - | $337.00 K(+764.1%) | $68.76 M(+0.5%) |
Dec 2013 | $68.45 M(+50.7%) | $39.00 K(-99.9%) | $68.45 M(-12.8%) |
Sep 2013 | - | $67.79 M(>+9900.0%) | $78.54 M(+115.9%) |
Jun 2013 | - | $596.00 K(+2609.1%) | $36.38 M(-20.0%) |
Mar 2013 | - | $22.00 K(-99.8%) | $45.48 M(+0.1%) |
Dec 2012 | $45.42 M(<-9900.0%) | $10.13 M(-60.5%) | $45.42 M(+28.8%) |
Sep 2012 | - | $25.63 M(+164.3%) | $35.28 M(+266.5%) |
Jun 2012 | - | $9.70 M(<-9900.0%) | $9.62 M(<-9900.0%) |
Mar 2012 | - | -$34.00 K(+88.9%) | -$63.00 K(+26.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2011 | -$50.00 K(-78.5%) | -$18.00 K(-18.2%) | -$50.00 K(+42.9%) |
Sep 2011 | - | -$22.00 K(-300.0%) | -$35.00 K(+169.2%) |
Jun 2011 | - | $11.00 K(-152.4%) | -$13.00 K(-43.5%) |
Mar 2011 | - | -$21.00 K(+600.0%) | -$23.00 K(-90.1%) |
Dec 2010 | -$233.00 K(-108.1%) | -$3000.00(<-9900.0%) | -$233.00 K(-49.2%) |
Sep 2010 | - | $0.00(-100.0%) | -$459.00 K(-32.7%) |
Jun 2010 | - | $1000.00(-100.4%) | -$682.00 K(-121.6%) |
Mar 2010 | - | -$231.00 K(+0.9%) | $3.16 M(+10.0%) |
Dec 2009 | $2.88 M(-237.7%) | -$229.00 K(+2.7%) | $2.88 M(+10.1%) |
Sep 2009 | - | -$223.00 K(-105.8%) | $2.61 M(+14.7%) |
Jun 2009 | - | $3.85 M(-842.7%) | $2.28 M(-210.9%) |
Mar 2009 | - | -$518.00 K(+4.9%) | -$2.06 M(-1.7%) |
Dec 2008 | -$2.09 M(-111.5%) | -$494.00 K(-11.3%) | -$2.09 M(+155.5%) |
Sep 2008 | - | -$557.00 K(+14.6%) | -$818.00 K(+213.4%) |
Jun 2008 | - | -$486.00 K(-12.1%) | -$261.00 K(-101.5%) |
Mar 2008 | - | -$553.00 K(-171.1%) | $17.27 M(-4.7%) |
Dec 2007 | $18.12 M(-65.5%) | $778.00 K(>+9900.0%) | $18.12 M(+1.9%) |
Sep 2007 | - | $0.00(-100.0%) | $17.79 M(-0.0%) |
Jun 2007 | - | $17.05 M(+5639.7%) | $17.79 M(+2278.7%) |
Mar 2007 | - | $297.00 K(-33.0%) | $748.00 K(-98.6%) |
Dec 2006 | $52.50 M(+40.5%) | $443.00 K(+7283.3%) | $52.50 M(-7.0%) |
Sep 2006 | - | $6000.00(+200.0%) | $56.43 M(-0.1%) |
Jun 2006 | - | $2000.00(-100.0%) | $56.51 M(-0.1%) |
Mar 2006 | - | $52.05 M(+1091.6%) | $56.58 M(+51.4%) |
Dec 2005 | $37.38 M(+713.1%) | $4.37 M(+4863.6%) | $37.38 M(-9.2%) |
Sep 2005 | - | $88.00 K(+12.8%) | $41.17 M(+0.2%) |
Jun 2005 | - | $78.00 K(-99.8%) | $41.09 M(+9.7%) |
Mar 2005 | - | $32.84 M(+302.3%) | $37.44 M(+714.5%) |
Dec 2004 | $4.60 M(-64.5%) | $8.16 M(<-9900.0%) | $4.60 M(-229.6%) |
Sep 2004 | - | -$2000.00(-99.9%) | -$3.55 M(-137.7%) |
Jun 2004 | - | -$3.57 M(<-9900.0%) | $9.42 M(-27.2%) |
Mar 2004 | - | $0.00(-100.0%) | $12.94 M(-0.1%) |
Dec 2003 | $12.95 M(+7518.2%) | $20.00 K(-99.8%) | $12.95 M(+0.0%) |
Sep 2003 | - | $12.96 M(<-9900.0%) | $12.95 M(<-9900.0%) |
Jun 2003 | - | -$42.00 K(-481.8%) | -$14.00 K(-108.6%) |
Mar 2003 | - | $11.00 K(-35.3%) | $163.00 K(-4.1%) |
Dec 2002 | $170.00 K(+11.1%) | $17.00 K(>+9900.0%) | $170.00 K(-13.7%) |
Sep 2002 | - | $0.00(-100.0%) | $197.00 K(-13.2%) |
Jun 2002 | - | $135.00 K(+650.0%) | $227.00 K(+54.4%) |
Mar 2002 | - | $18.00 K(-59.1%) | $147.00 K(-3.9%) |
Dec 2001 | $153.00 K(-99.8%) | $44.00 K(+46.7%) | $153.00 K(-99.7%) |
Sep 2001 | - | $30.00 K(-45.5%) | $60.75 M(-0.3%) |
Jun 2001 | - | $55.00 K(+129.2%) | $60.91 M(-35.3%) |
Mar 2001 | - | $24.00 K(-100.0%) | $94.07 M(-3.4%) |
Dec 2000 | $97.37 M(>+9900.0%) | $60.64 M(>+9900.0%) | $97.37 M(+165.1%) |
Sep 2000 | - | $185.00 K(-99.4%) | $36.73 M(+0.5%) |
Jun 2000 | - | $33.22 M(+900.0%) | $36.54 M(+999.7%) |
Mar 2000 | - | $3.32 M(>+9900.0%) | $3.32 M(>+9900.0%) |
Dec 1999 | $312.00 K | - | - |
Jun 1999 | - | $1000.00(>+9900.0%) | $1000.00(>+9900.0%) |
Mar 1999 | - | $0.00 | $0.00 |
FAQ
- What is Insmed Incorporated annual cash flow from financing activities?
- What is the all time high annual CFF for Insmed Incorporated?
- What is Insmed Incorporated annual CFF year-on-year change?
- What is Insmed Incorporated quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Insmed Incorporated?
- What is Insmed Incorporated quarterly CFF year-on-year change?
- What is Insmed Incorporated TTM cash flow from financing activities?
- What is the all time high TTM CFF for Insmed Incorporated?
- What is Insmed Incorporated TTM CFF year-on-year change?
What is Insmed Incorporated annual cash flow from financing activities?
The current annual CFF of INSM is $168.44 M
What is the all time high annual CFF for Insmed Incorporated?
Insmed Incorporated all-time high annual cash flow from financing activities is $793.27 M
What is Insmed Incorporated annual CFF year-on-year change?
Over the past year, INSM annual cash flow from financing activities has changed by -$624.83 M (-78.77%)
What is Insmed Incorporated quarterly cash flow from financing activities?
The current quarterly CFF of INSM is $397.20 M
What is the all time high quarterly CFF for Insmed Incorporated?
Insmed Incorporated all-time high quarterly cash flow from financing activities is $781.49 M
What is Insmed Incorporated quarterly CFF year-on-year change?
Over the past year, INSM quarterly cash flow from financing activities has changed by +$395.95 M (+31701.44%)
What is Insmed Incorporated TTM cash flow from financing activities?
The current TTM CFF of INSM is $1.30 B
What is the all time high TTM CFF for Insmed Incorporated?
Insmed Incorporated all-time high TTM cash flow from financing activities is $1.30 B
What is Insmed Incorporated TTM CFF year-on-year change?
Over the past year, INSM TTM cash flow from financing activities has changed by +$516.41 M (+65.49%)